Company
United StatesPublic company, NASDAQ: CLPTClearPoint Neuro, Inc. (NASDAQ: CLPT), Irvine, CA – FDA Inspections
Inspection records and compliance data for ClearPoint Neuro, Inc. in Irvine, California. 2 FDA inspections on record, 1 Form 483, last inspected July 25, 2018. Publicly traded as NASDAQ: CLPT.
Company Profile
This profile covers ClearPoint Neuro, Inc. based in Irvine, California, United States.
FDA Inspection History
- FDA inspections
- 2
- OAI
- 0
- VAI
- 1
- NAI
- 1
- Form 483s
- 1
- Warning letters
- 0
First inspected September 10, 2014. Last inspected July 25, 2018.
Most cited issue areas
- Lack of or inadequate procedures1 inspection
- Lack of Written MDR Procedures1 inspection
- Report of Death or Serious Injury1 inspection
FDA inspections (2)
| Date | Result | FDA center(s) | Insp. # |
|---|---|---|---|
| July 25, 2018 | VAI | Medical Devices & Rad Health · Postmarket Assurance: Devices | 1060878 |
| September 10, 2014 | NAI | Medical Devices & Rad Health · Compliance: Devices | 895130 |
FDA documents
No Form 483s, Warning Letters or EIRs on record.
Related Companies (10)
Companies with similar regulatory profiles, compliance history, and operations.
Company Information
Name
ClearPoint Neuro, Inc.
Stock ticker
CLPT
Exchange
NASDAQ
Share price
$8.71
Market cap
$279.0M
Price as of
November 6, 2026
FEI Number
3002838670
Address
5 Musick, Irvine, California 92618, United States
Country
United States
ID: 6d7c9cb9-14d9-4785-8538-4ca6d28f3e70